Nature's Sunshine Products, Inc. - Common Stock (NATR)
Healthcare › Pharmaceutical Preparations
Price History
Feb 9, 2026 — Jul 6, 2026Investment Snapshot
- Trading 47% above Graham Number — above intrinsic value estimate
- Piotroski F-Score 7/9 — financially strong with improving fundamentals
- ROE of 14.6% — below-average profitability
- Revenue growing at 6% annually
Nature's Sunshine Products, Inc. - Common Stock (NATR) is a Healthcare company operating in Pharmaceutical Preparations, listed on the NASDAQ , with a market capitalisation of $374 million . Key value metrics: P/E ratio 18.2, P/B ratio 2.91, Piotroski F-Score 7 out of 9 (strong financial health) .
Value Score
Key Metrics
Current vs 5-Year Average
Based on 5 years of SEC filingsRevenue & Net Income
Financial Statements
| Metric | FY22 | FY23 | FY24 |
|---|---|---|---|
| Revenue | $X.XB | $X.XB | $X.XB |
| Gross Profit | $X.XB | $X.XB | $X.XB |
| Operating Income | $X.XB | $X.XB | $X.XB |
| Net Income | $X.XB | $X.XB | $X.XB |
| EBITDA | $X.XB | $X.XB | $X.XB |
| Total Assets | $X.XB | $X.XB | $X.XB |
| Total Liabilities | $X.XB | $X.XB | $X.XB |
Nature's Sunshine Products, Inc. - Common Stock — Fundamental Analysis Summary
Nature's Sunshine Products, Inc. - Common Stock (NATR) is currently trading 47% above its Graham Number of $14.48, suggesting the market price exceeds Benjamin Graham's intrinsic value estimate. The stock carries a reasonable trailing P/E ratio of 18.2x.
On financial health, NATR shows a strong Piotroski F-Score of 7/9, indicating improving fundamentals across profitability, leverage, and efficiency, and modest return on equity of 14.6% (sector average: -20.6%), and minimal leverage with a debt-to-equity ratio of 0.02.
StockPik's composite Value Score for NATR is 92/100 — placing it in undervalued territory. The score is built from ten fundamental signals: P/E, P/B, PEG ratio, P/S ratio, return on equity, gross margin, debt-to-equity, current ratio, dividend yield, and Piotroski F-Score.
NATR reports a high gross margin of 72.6% (sector average: 39.4%) and a modest operating margin of 6.0%.
NATR shows revenue growing at 6% year-over-year, with earnings growing at 154%.